title: [Benign prostatic hyperplasia and urolithiasis].
abstract: Benign prostatic hyperplasia and urolithiasis are widespread diseases and are two of the most important elements of the urological therapeutic spectrum. This article gives an overview of the most interesting publications on the subject from the past few years. Particularly the link with cardiovascular risk factors like obesity and diabetes appears to be stronger than supposed. The diagnostic and therapeutic tools of the future will be developed with respect to this.
authors.affiliation: Klinik für Urologie, Universitätsmedizin Mannheim, Theodor-Kutzer-Ufer 1, 68135 Mannheim.
authors.forename: P
authors.initials: P
authors.lastname: Krombach
authors.forename: M S
authors.initials: MS
authors.lastname: Michel
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology* / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008297:Male; D009765:Obesity / Q000209:etiology / Q000517:prevention & control; D011470:Prostatic Hyperplasia / Q000150:complications* / Q000175:diagnosis / Q000628:therapy*; D052878:Urolithiasis / Q000150:complications* / Q000175:diagnosis / Q000628:therapy*
references.citation: BJU Int. 2009 Sep;104(6):820-5
references.pmid: 19239441
references.citation: Eur Urol. 2009 Feb;55(2):368-75
references.pmid: 19022557
references.citation: J Urol. 2010 Feb;183(2):571-5
references.pmid: 20018330
references.citation: Ann Intern Med. 1967 Dec;67(6):1133-48
references.pmid: 6061930
references.citation: Nephrol Dial Transplant. 2005 Feb;20(2):468-9
references.pmid: 15673704
references.citation: J Urol. 2010 Mar;183(3):1017-21
references.pmid: 20092842
references.citation: J Urol. 2010 Feb;183(2):585-9
references.pmid: 20018321
references.citation: Urology. 2009 Apr;73(4):811-5
references.pmid: 19195694
references.citation: Eur Urol. 2003 Oct;44(4):461-6
references.pmid: 14499682
references.citation: Int J Cardiol. 2010 Oct 29;144(3):452
references.pmid: 19359054
references.citation: Urology. 2010 Mar;75(3):658-63
references.pmid: 20035978
references.citation: Eur Urol. 2007 Sep;52(3):827-34
references.pmid: 17207910
references.citation: Urology. 2009 Apr;73(4):802-6
references.pmid: 19193422
references.citation: Obes Res. 2004 Jan;12(1):106-13
references.pmid: 14742848
references.citation: J Urol. 2009 Nov;182(5):2105-6
references.pmid: 19758648
references.citation: BJU Int. 2010 May;105(9):1296-300
references.pmid: 20346053
references.citation: Arch Esp Urol. 2008 Nov;61(9):1037-43
references.pmid: 19140585
references.citation: Urology. 2009 Jan;73(1):90-4
references.pmid: 18995889
references.citation: Eur Urol. 2009 Nov;56(5):798-809
references.pmid: 19595501
references.citation: Urology. 2010 Jan;75(1):4-7
references.pmid: 20109697
references.citation: Prostate. 2009 Dec 1;69(16):1774-80
references.pmid: 19670242
references.citation: Eur Urol. 2008 Feb;53(2):382-89
references.pmid: 17566639
references.citation: J Urol. 2009 Dec;182(6 Suppl):S27-31
references.pmid: 19846130
references.citation: J Urol. 2010 Apr;183(4):1424-8
references.pmid: 20172565
references.citation: Eur Urol. 2010 Jan;57(1):123-31
references.pmid: 19825505
references.citation: Eur Urol. 2003 Dec;44(6):709-13
references.pmid: 14644124
references.citation: Cardiovasc Intervent Radiol. 2010 Apr;33(2):355-61
references.pmid: 19908092
references.citation: World J Urol. 2009 Aug;27(4):541-5
references.pmid: 19184038
references.citation: Urology. 2009 Dec;74(6):1216-21
references.pmid: 19815264